Report cover image

Cancer Markers

Publisher Kalorama Information
Published Mar 24, 2016
Length 155 Pages
SKU # KLI5948135

Description

Cancer Markers

Cancer Markers contains revenue assessment, analysis, and competitive review for tests for oncology using biomarkers. Multiple firms manufacture a range of technologies – histology/cytology, immunohistochemistry, in situ hybridization, immunoassays - tumor markers, flow cytometry, rapid tests, and molecular marker-based technologies – to determine risk for cancer, screen for cancer, test for cancer, and help in prognosis and personalization of therapy.

Cancer Markers provides the following information: global cancer biomarkers diagnostic revenues, 2015 and 2020 (IHC, ISH, immunoassays, flow, rapid, molecular); global cancer biomarkers diagnostic market percentage (IHC, ISH, flow cytometry, molecular-based assays, NMP22, FOB, PSA, CEA, CA125, AFP, other tumor markers); selected extensively used tumor markers; selected biomarkers and biomarker panels to determine risk of cancer, and manufacturers developing/marketing these biomarkers; selected biomarkers and biomarker panels for cancer screening, and manufacturers developing/marketing these biomarkers; selected biomarkers and biomarker panels for diagnosis and/or monitoring of cancer, and manufacturers developing/marketing these biomarkers; selected biomarkers and biomarker panels to predict prognosis of cancer, and manufacturers developing/marketing these biomarkers; selected biomarkers and biomarker panels to predict response to therapy, and manufacturers developing/marketing these biomarkers; selected FDA-cleared/approved companion diagnostic tests, and manufacturers developing/marketing these biomarkers; selected manufacturers developing/marketing cancer tests; common next generation molecular test traits; selected sample preparation reagents; and selected cancer test innovations, 2015. Abbott Laboratories, Alere Inc., bioMérieux SA, Hologic, Inc., Illumina, Inc., QIAGEN N.V., Roche, and Thermo Fisher Scientific, Inc. are among the manufacturers discussed in the competitive analysis.

Table of Contents

155 Pages
    • MARKET
    • SCOPE AND METHODOLOGY
    • Estimated Global Incidence and Mortality due to Cancer, 2012 – By Regions of the World
    • Selected Widely Used Tumor Markers
    • CANCER RISK ASSESSMENT
    • CANCER SCREENING
    • CANCER MONITORING
    • CANCER PROGNOSIS ASSESSMENT
    • PERSONALIZED MEDICINE/PRECISION TESTING
    • COMPETITION IN CANCER BIOMARKERS
    • MOLECULAR MARKERS
    • PRECISION MEDICINE
    • Worldwide Cancer Biomarkers Diagnostic Market – 2015 and 2020 (IHC, ISH, Immunoassays, Flow, Rapid, Molecular) $ millions
    • Selected International Agreements
    • 20/20 GENESYSTEMS, INC.
    • ABBOTT LABORATORIES
    • ABCODIA LTD.
    • ALERE INC. (ABBOTT)
    • AMBRY GENETICS CORP.
    • ASURAGEN, INC.
    • ATHENA DIAGNOSTICS, INC. (AQUEST DIAGNOSTICS BUSINESS)
    • BIOMÉRIEUX SA
    • BIOTHERANOSTICS, INC. (A BIOMÉRIEUX COMPANY)
    • CANCER GENETICS, INC.
    • GENOMIC HEALTH, INC.
    • GENOPTIX (A NOVARTIS COMPANY)
    • HOLOGIC, INC.
    • ILLUMINA, INC.
    • MYRIAD GENETICS, INC.
    • QIAGEN N.V.
    • ROCHE
    • THERMO FISHER SCIENTIFIC, INC.
    • WAKO PURE CHEMICAL INDUSTRIES, LTD.,

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us